Lifestyle and precision diabetes medicine: will genomics help optimise the prediction, prevention and treatment of type 2 diabetes through lifestyle therapy?

Diabetologia

Volumn 60, Issue 5, 2017, Pages 784-792

  Franks, Paul W ^a,b,c   Poveda, Alaitz ^a  

^a LUND UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Biomarkers; Lifestyle; Precision medicine; Review; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER;

BODY COMPOSITION; DIET SUPPLEMENTATION; DISEASE COURSE; EVIDENCE BASED MEDICINE; GENE LOCUS; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENETIC VARIATION; GENOMICS; HUMAN; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERSONALIZED MEDICINE; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RESTING ENERGY EXPENDITURE; REVIEW; RISK FACTOR; TREATMENT RESPONSE; BLOOD; DIABETES MELLITUS, TYPE 2; GENETICS; LIFESTYLE; METABOLISM; PROCEDURES;

BIOMARKERS; DIABETES MELLITUS, TYPE 2; GENOMICS; HUMANS; LIFE STYLE; PRECISION MEDICINE;

EID: 85010734919     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-017-4207-5     Document Type: Review

References (47)

1. National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease (2011) Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. National Academies Press, Washington, DC
2. Sturtevant AH (1917) Genetic factors affecting the strength of linkage in Drosophila. Proc Natl Acad Sci U S A 3:555–558
3. Watson JD, Crick FH (1953) Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 171:737–738
4. Venter JC, Adams MD, Myers EW et al (2001) The sequence of the human genome. Science 291:1304–1351
5. Lander ES, Linton LM, Birren B et al (2001) Initial sequencing and analysis of the human genome. Nature 409:860–921
6. Crick F (1970) Central dogma of molecular biology. Nature 227:561–563
7. Rutter GA, Chabosseau P, Bellomo EA et al (2016) Intracellular zinc in insulin secretion and action: a determinant of diabetes risk? Proc Nutr Soc 75:61–72
8. Schoonjans K, Staels B, Auwerx J (1996) Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37:907–925
9. Salas-Salvado J, Bullo M, Babio N et al (2011) Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 34:14–19
10. Yaghootkar H, Lotta LA, Tyrrell J et al (2016) Genetic evidence for a link between favorable adiposity and lower risk of type 2 diabetes, hypertension, and heart disease. Diabetes 65:2448–2460
11. Delahanty LM, Pan Q, Jablonski KA et al (2014) Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the diabetes prevention program. Diabetes Care 37:2738–2745
12. Loffler-Wirth H, Willscher E, Ahnert P et al (2016) Novel anthropometry based on 3D-Bodyscans applied to a large population based cohort. PLoS One 11, e0159887
13. Herman WH, Edelstein SL, Ratner RE et al (2013) Effectiveness and cost-effectiveness of diabetes prevention among adherent participants. Am J Manag Care 19:194–202
14. McTigue KM, Conroy MB, Bigi L, Murphy C, McNeil M (2009) Weight loss through living well: translating an effective lifestyle intervention into clinical practice. Diabetes Educ 35:199–208
15. Li L, Cheng WY, Glicksberg BS et al (2015) Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Sci Transl Med 7:311ra174
16. Baier LJ, Muller YL, Remedi MS et al (2015) ABCC8 R1420H loss-of-function variant in a Southwest American Indian community: association with increased birth weight and doubled risk of type 2 diabetes. Diabetes 64:4322–4332
17. Druker BJ, Guilhot F, O'Brien SG et al (2006) Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355:2408–2417
18. Kwak EL, Bang YJ, Camidge DR et al (2010) Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363:1693–1703
19. Tang Y, Axelsson AS, Spegel P et al (2014) Genotype-based treatment of type 2 diabetes with an α2A-adrenergic receptor antagonist. Sci Transl Med 6:257ra139
20. Boule NG, Weisnagel SJ, Lakka TA et al (2005) Effects of exercise training on glucose homeostasis: the HERITAGE family study. Diabetes Care 28:108–114
21. Bohm A, Weigert C, Staiger H, Haring HU (2016) Exercise and diabetes: relevance and causes for response variability. Endocrine 51:390–401
22. Bouchard C, Blair SN, Church TS et al (2012) Adverse metabolic response to regular exercise: is it a rare or common occurrence? PLoS One 7, e37887
23. Weyrich P, Stefan N, Haring HU, Laakso M, Fritsche A (2007) Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes. J Mol Med 85:107–117
24. Perusse L, Rice T, Province MA et al (2000) Familial aggregation of amount and distribution of subcutaneous fat and their responses to exercise training in the HERITAGE family study. Obes Res 8:140–150
25. Bouchard C, Tremblay A, Despres JP et al (1994) The response to exercise with constant energy intake in identical twins. Obes Res 2:400–410
26. Bouchard C, Tremblay A, Despres JP et al (1990) The response to long-term overfeeding in identical twins. N Engl J Med 322:1477–1482
27. Ahmad S, Rukh G, Varga TV et al (2013) Gene × physical activity interactions in obesity: combined analysis of 111,421 individuals of European ancestry. PLoS Genet 9, e1003607
28. Andreasen CH, Stender-Petersen KL, Mogensen MS et al (2008) Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes 57:95–101
29. Vimaleswaran KS, Li S, Zhao JH et al (2009) Physical activity attenuates the body mass index-increasing influence of genetic variation in the FTO gene. Am J Clin Nutr 90:425–428
30. Rampersaud E, Mitchell BD, Pollin TI et al (2008) Physical activity and the association of common FTO gene variants with body mass index and obesity. Arch Intern Med 168:1791–1797
31. Franks PW, Jablonski KA, Delahanty LM et al (2008) Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the diabetes prevention program. Diabetologia 51:2214–2223
32. Kilpeläinen TO, Qi L, Brage S et al (2011) Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med 8, e1001116
33. Young AI, Wauthier F, Donnelly P (2016) Multiple novel gene-by-environment interactions modify the effect of FTO variants on body mass index. Nat Commun 7:12724
34. Gerken T, Girard CA, Tung YC et al (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318:1469–1472
35. Grunnet LG, Brons C, Jacobsen S et al (2009) Increased recovery rates of phosphocreatine and inorganic phosphate after isometric contraction in oxidative muscle fibers and elevated hepatic insulin resistance in homozygous carriers of the A-allele of FTO rs9939609. J Clin Endocrinol Metab 94:596–602
36. Smemo S, Tena JJ, Kim KH et al (2014) Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507:371–375
37. Claussnitzer M, Dankel SN, Kim KH et al (2015) FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 373:895–907
38. Xiang L, Wu H, Pan A et al (2016) FTO genotype and weight loss in diet and lifestyle interventions: a systematic review and meta-analysis. Am J Clin Nutr 103:1162–1170
39. Palla L, Higgins JP, Wareham NJ, Sharp SJ (2010) Challenges in the use of literature-based meta-analysis to examine gene-environment interactions. Am J Epidemiol 171:1225–1232
40. Livingstone KM, Celis-Morales C, Papandonatos GD et al (2016) FTO genotype and weight loss: systematic review and meta-analysis of 9563 individual participant data from eight randomised controlled trials. BMJ 354:i4707
41. Papandonatos GD, Pan Q, Pajewski NM et al (2015) Genetic predisposition to weight loss and regain with lifestyle intervention: analyses from the diabetes prevention program and the look AHEAD randomized controlled trials. Diabetes 64:4312–4321
42. Nettleton JA, Follis JL, Ngwa JS et al (2015) Gene × dietary pattern interactions in obesity: analysis of up to 68 317 adults of European ancestry. Hum Mol Genet 24:4728–4738
43. Goran MI, Poehlman ET (1992) Endurance training does not enhance total energy expenditure in healthy elderly persons. Am J Phys 263:E950–E957
44. Shephard RJ (2003) Limits to the measurement of habitual physical activity by questionnaires. Br J Sports Med 37:197–206
45. Lobelo F, Kelli HM, Tejedor SC et al (2016) The wild wild west: a framework to integrate mhealth software applications and wearables to support physical activity assessment, counseling and interventions for cardiovascular disease risk reduction. Prog Cardiovasc Dis 58:584–594
46. Jakicic JM, Davis KK, Rogers RJ et al (2016) Effect of wearable technology combined with a lifestyle intervention on long-term weight loss: the IDEA randomized clinical trial. JAMA 316:1161–1171
47. Zeevi D, Korem T, Zmora N et al (2015) Personalized nutrition by prediction of glycemic responses. Cell 163:1079–1094